BSX vs ZBH
BSX and ZBH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BSXBOSTON SCIENTIFIC CORPORATION | ZBHZIMMER BIOMET HOLDINGS, INC. |
|---|---|---|
| Market cap | $63.51B | $18.44B |
| P/E (TTM) | 17.7 | 23.5 |
| P/B | 2.55 | 1.46 |
| P/S | 3.1x | 2.2x |
| Dividend yield | — | 1.03% |
| Revenue | $21.00B(TTM) | $8.51B(TTM) |
| Revenue growth (YoY) | 19.9% | 7.2% |
| Net income | $3.67B(TTM) | $806.70M(TTM) |
| Earnings growth (YoY) | 56.7% | -22.0% |
| EPS, diluted | $2.47(TTM) | $4.12(TTM) |
| EBIT margin | 18.0% | 13.3% |
| ROE | 11.6% | 5.6% |
| ROIC | 10.0% | 5.0% |
| Piotroski F | 8/9 | 6/9 |
| 1y total return | -56.8% | -3.5% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: BSX vs ZBH
| 지표 | BSX | ZBH |
|---|---|---|
| 최종 가치 | $18.8K | $8.8K |
| 총수익률 | +88.1% | -12.4% |
| CAGR | +6.3% | -1.3% |
| 변동성 | 27.6% | 28.6% |
| 샤프 | 0.21 | -0.05 |
| 소르티노 | 0.28 | -0.06 |
| 최대 낙폭 | -61.5% | -53.5% |
공통 거래일 2600일 기준, 2016-06-30 → 2026-11-02 · 무위험수익률 4.16% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)